Skip to content

GLP-1 calculator

GLP-1 Calorie Calculator

How many calories to eat a day on Ozempic, Wegovy, Mounjaro or Zepbound, from your sex, age, height, weight and activity. Same formula as the Mingo app, with every step shown.

Updated

Units
Sex

"Other" uses the average of the female and male equations, as the app does.

Height
Activity level

Quick answer

There's no calorie number set by the medicine itself. In the main semaglutide and tirzepatide trials, people aimed for about 500 kcal a day below what they burned. This calculator estimates your daily burn with the Mifflin-St Jeor equation, subtracts 750 kcal, and never goes below 1,200 kcal for women or 1,500 for men. At a BMI of 22 or less it drops the deficit.

Example daily calorie targets

Same formula as the calculator, for age 45: women at 5 ft 4 in (163 cm), men at 5 ft 9 in (175 cm).

Women
WeightSedentaryLightly activeActiveVery active
130 lb (59 kg)1,2051,2051,2051,345
160 lb (73 kg)1,2011,2011,3531,469
190 lb (86 kg)1,2051,3081,4981,593
220 lb (100 kg)1,2091,4361,5431,659
250 lb (113 kg)1,3701,4361,5431,659
280 lb (127 kg)1,3781,4361,5431,659
310 lb (141 kg)1,3781,4361,5431,659
Men
WeightSedentaryLightly activeActiveVery active
130 lb (59 kg)1,5021,5021,5011,501
160 lb (73 kg)1,5001,5011,5021,501
190 lb (86 kg)1,5021,5001,5061,593
220 lb (100 kg)1,5021,5001,5431,659
250 lb (113 kg)1,5021,5001,5431,659
280 lb (127 kg)1,5021,5001,5431,659
310 lb (141 kg)1,5021,5001,5431,659

Track your calories next to your doses

Mingo sets this calorie goal for you, logs meals by photo, voice or barcode, and shows each day's calories and protein against it.

Rated 4.7 out of 5 on the App Store · 1,579 ratings

The five steps behind your number

Most calorie calculators show one number and hide the rules. Here is every step the calculator, and the Mingo app, takes:

  1. Resting burn. The Mifflin-St Jeor equation estimates what your body burns at rest from your sex, age, height and weight. A systematic review found it the most accurate of the common equations in adults with and without obesity (Frankenfield et al., 2005). For “Other”, the calculator averages the female and male versions.
  2. Daily burn. That figure is multiplied by an activity factor (below), which gives an estimate of what you burn in a day. The calculator shows it as your maintenance number.
  3. Deficit. 750 kcal is subtracted, unless your BMI is 22 or lower.
  4. Limits. The target is held between a floor and an activity cap.
  5. Macros. The target is split into protein, fat and carbs. Protein comes from the GLP-1 protein calculator formula, fat is 27.5% of calories, and carbs fill the rest up to 150 g a day. The final number is the sum of those three.
Activity level Activity factor Highest target
Sedentary 1.2 1,800 kcal
Lightly active 1.375 2,000 kcal
Active 1.55 2,200 kcal
Very active 1.725 2,400 kcal
Sex Lowest target
Female 1,200 kcal
Male 1,500 kcal
Other 1,350 kcal

The floors match the low end of the calorie ranges in the US obesity guideline: 1,200 to 1,500 kcal a day for women and 1,500 to 1,800 for men (Jensen et al., 2014).

500 or 750: where the deficit comes from

The big trials that got semaglutide and tirzepatide approved for weight loss paired the weekly shot with diet counselling aimed at about 500 kcal a day below each person’s estimated burn, plus at least 150 minutes of activity a week (STEP 1; SURMOUNT-1 protocol, section 5.3). The US obesity guideline allows a deficit of 500 or 750 kcal a day (Jensen et al., 2014).

Mingo uses the 750 end. That’s a design choice, not a trial number: people on these medicines tend to eat less than a 500 kcal deficit implies, and a target close to what they actually eat is easier to track against. The floors stop it from going too low.

Why so many results land near 1,200 to 1,700 kcal

Try a few weights and you’ll notice the number barely moves. Two rules cause that:

  • Carbs are capped at 150 g a day. When your calories leave room for more carbs than that, the extra isn’t moved to fat or protein; the total comes down instead. For larger or more active people this cap, not the 750 kcal deficit, sets the number.
  • The floors. For most men below the “Active” level, and for many women, the result is simply the floor.

So a heavier weight raises your protein a little, and with it the total, but not by much. The example tables near the top of this page show it: read down a column to see how the target changes as weight comes off.

The BMI 22 rule from the tirzepatide trial

The SURMOUNT-1 protocol told dietitians to recalculate intake with no calorie deficit once a participant’s BMI reached 22 (protocol, section 5.3.1). The calculator does the same: at a BMI of 22 or below it drops the 750 kcal deficit.

Because of the 150 g carb cap, the result can still sit below your maintenance number, which the calculator shows next to it. If you’re at or near a healthy weight, ask your prescriber or a dietitian whether you should be eating closer to maintenance. Below a BMI of 18.5, the underweight range, don’t aim for a deficit at all.

When your appetite is far below the target

On a GLP-1 medicine the usual problem isn’t overeating; it’s eating so little that protein and other nutrients fall short. Nutrition experts put enough protein and nutrient-dense food first during GLP-1 treatment (joint advisory, 2025). If your appetite changes across the week, look at your weekly average rather than a single day, and:

  • Eat the protein part of each meal first.
  • Pick dense foods: Greek yogurt, eggs, fish, tofu or a protein shake.
  • Use more, smaller meals when a normal plate is too much.

If you’re well under your target most days, or losing weight faster than your prescriber expects, tell them.

If you take insulin or a sulfonylurea

Eating less while on insulin or a sulfonylurea such as glipizide or glimepiride raises the risk of low blood sugar, and the semaglutide label warns that the risk is higher when these medicines are combined (Ozempic prescribing information, section 5). Talk to your prescriber before you cut calories; they may change those doses.

What this calculator doesn’t do

  • It doesn’t change with your medicine or dose. We haven’t found guidance that sets calories by GLP-1 dose.
  • It doesn’t use body fat or a measured resting burn, so it can be off for very muscular people or anyone whose burn differs from the equation.
  • It isn’t for pregnancy, breastfeeding, eating disorders, kidney disease, or a diet your care team has set. In those cases their target comes first.
  • It isn’t a substitute for a dietitian, who can look at what you actually eat.

Track it next to your doses

In the Mingo app this same calorie goal is set during onboarding from your sex, age, height, weight and activity. You log meals by photo, voice, text or barcode, and each day’s calories and protein show against the goal, next to your doses, side effects and weight.

Frequently asked questions

How many calories should I eat on a GLP-1 medicine?

It depends on your size, age, sex and activity. The semaglutide and tirzepatide trials aimed for about 500 kcal a day below what each person burned. For most adults this calculator lands between about 1,200 and 1,700 kcal a day; enter your details for your number.

Do I need to count calories on Ozempic, Wegovy, Mounjaro or Zepbound?

Not necessarily. The trials paired the medicine with a reduced-calorie diet and dietitian advice, not strict counting. A target helps most when appetite is very low, so you can see whether you're eating too little, and too little protein.

Is it bad to eat too few calories on a GLP-1?

It can be. Very low intake makes it hard to get enough protein and other nutrients, and part of rapid weight loss is lean mass. That's why the calculator has a floor of 1,200 kcal for women and 1,500 for men. If you regularly eat much less than your target, tell your prescriber.

Does my dose change how many calories I need?

No source we know of sets calories by medicine or dose, so the calculator doesn't ask for it. Higher doses usually make it easier to eat less; the target stays based on your body and activity.

Why does the calculator subtract 750 kcal and not 500?

The trials prescribed about 500 kcal a day; US obesity guidelines allow 500 to 750. Mingo uses 750 because people on these medicines tend to eat less than a 500 kcal deficit suggests, so the target sits closer to what they actually eat. The floors keep it from going too low.

Why is my target the same at different weights?

At higher weights two limits take over: carbs are capped at 150 g a day, and the target never drops below 1,200 kcal for women or 1,500 for men. Above those limits, a heavier weight raises protein a little but not the calorie total.

Will my calorie target change as I lose weight?

Yes. It's based on your current weight, so recalculate every few kilos or pounds. When your BMI reaches 22 the calculator drops the 750 kcal deficit, as the tirzepatide trial did. The Mingo app recalculates when you log a new weight.

Is this the same calorie goal the Mingo app gives me?

Yes. The calculator runs the same formula the app uses to set your daily calorie goal from your sex, age, height, weight and activity level, so the two numbers match.

Sources

Updated .

  1. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022
  2. SURMOUNT-1 study protocol I8F-MC-GPHK(b), section 5.3.1 (diet: ~500 kcal/day deficit; no deficit once BMI ≤ 22). ClinicalTrials.gov NCT04184622
  3. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
  4. Jensen MD et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation 2014
  5. Mifflin MD et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990
  6. Frankenfield D et al. Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J Am Diet Assoc 2005
  7. Ozempic (semaglutide) injection, US prescribing information. Novo Nordisk
  8. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the ACLM, ASN, OMA and The Obesity Society. Am J Lifestyle Med 2025

GLP-1 calculators and dose charts